We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The UK’s price watchdog says women should be advised that a copper intrauterine device is more effective than the morning-after pill for emergency contraception. Read More
Australia’s Therapeutic Goods Administration released guidance on its website to help sponsors through the process of registering Class IV in vitro diagnostics in the Australian Register of Therapeutic Goods. Read More
The FDA said that plasma fibrinogen can be used as a biomarker in interventional clinical trials examining patients at high risk for exacerbations or all-cause mortality in chronic obstructive pulmonary disease. Read More